Advances in psychiatry and nuerology


ISSN 1230-2813
ISSN online 2720-5371 

JCR Impact Factor: 1.5
CiteScore 2025: 2.0
MNiSW: 70
Index Copernicus 2023: 153.00

Indexed in PubMed.

We encourage our Readers to continue, renew or start a subscription to the quarterly in 2025. The journal needs your support – to become better and better and to be able to offer you more.

Editorial panel
Submitting and reviewing works online

Archive 1992–2014

1997, tom 6, zeszyt 1
Neurogenetyka

Perspectives of gene therapy in neurological diseases

JERZY NOWAK1, DANUTA JANUSZKIEWICZ-LEWANDOWSKA1
1. Zakładu Genetyki Człowieka PAN w Poznaniu
Postępy Psychiatrii i Neurologii, 1997, 6, 61-65
Keywords: gene therapy, gene transfer, Alzheimer’s disease, Parkinson’s disease
Summary

Gene therapy is one of the most rapidly developing branches of medicine. Gene therapy provides enormous possibilities of treatment of many acquired and inborn neurological conditions, in which a definite genetic defect has been identified. The application of specific vectors allows to introduce therapeutic genes into target cells by means of the ex vivo and in vivo methods. Since promising results have been obtained in animal models, it can be assumed that in the future the gene transfer therapy may be used in the treatment of parkinsonism and Alzheimer's disease. In clinical trials using suicides' genes transfer and gancyclovire, regression of cerebral tumors has been noted. It may be hoped that in the future the gene transfer therapy will be a common method of neurological diseases prevention and treatment.

Correspondence address
Dr Jerzy Nowak,
Zakład Genetyki Człowieka PAN,
ul. Strzeszyńska 32,
60-479 Poznań
You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links